Azora Therapeutics, Inc. (DE)
AZR is one of 2 listed share classes under this CIK; the filings below cover all of them.
At a glance
Most recent filing on November 4, 2026 — a conversion by Davidson Matt on Nov 2, 2026.
We hold 13 Form 4 lines, going back to July 1, 2026.
Insider trades
How to read a Form 45 of 13 shown
- Davidson Matt President and CEO101.298 sharesConversion
- Davidson Matt President and CEO524.954 sharesConversion
- Davidson Matt President and CEO—Conversion
- Davidson Matt President and CEO—Conversion
- Saiki Julie Chief Strategy Officer626.252 sharesConversion
CEO pay
What the company reported for its principal executive officer, usually the CEO, in the pay-versus-performance table of its proxy statement. The total counts shares and options at their value on the day they were granted. Actually paid counts them at the change in their value during the year, so it can be far higher or lower than the total, and negative. A dash means the company reported no amount.
Cary Claiborne, fiscal year ended Dec 31, 2025: total $890,653, actually paid $600,167. First reported Aug 24, 2026.
Earlier fiscal years are part of the subscription.